⌘K

Login Start Free

Home/Filings/144/0001628280-25-047588

144//SEC Filing

Werewolf Therapeutics, Inc. 144

Accession 0001628280-25-047588

CIK 0001691428other

View on SEC.gov Company Profile

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 5:10 PM ET

Size

255.7 KB

Accession

0001628280-25-047588

Documents

2 files

Issuer

UBS Oncology Impact Fund L.P.

CIK 0001691428

Entity typeother

IncorporatedCayman Islands

Related Parties

1

filerCIK 0001691428

Filing Metadata

Form type: 144
Filed: Oct 29, 8:00 PM ET
Accepted: Oct 30, 5:10 PM ET
Size: 255.7 KB

View on SEC.gov